Compare Costco Wholesale Corporation (COST) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Twist Bioscience Corp — how do they compare? Costco Wholesale Corporation trades at $921.77 (market cap $408.78B), while Twist Bioscience Corp trades at $92.62 (market cap $5.77B). The key difference: Costco Wholesale Corporation is far larger — about 70.8× Twist Bioscience Corp's market cap, and Costco Wholesale Corporation pays a 0.64% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| COST | TWST | |
|---|---|---|
Market Cap | $408.78B | $5.77B |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $102.88 |
52-Week Low | $849.63 | $24.16 |
Enterprise Value | $396.92B | $5.69B |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COST trades at $926.43, up 1.11% today, with a bearish technical signal but strong fundamentals. Revenue grew to $275.24B in 2025, with net income up to $8.10B, and March 2026 sales surged 11.3% year-over-year (Costco report, April 8, 2026). Valuation ratios are elevated, with a P/E of 46.6, while analyst consensus is bullish with a $1,120 price target. Recent membership fee hikes and institutional buying support growth prospects.
Outlook remains positive due to steady revenue growth and high membership renewal rates, but risks include rich valuations and competitive pressures. The stock offers long-term value if pullbacks occur, with earnings momentum key for upside. Bearish technicals suggest near-term caution, though fundamentals underpin investor confidence.
TWST trades at $90.35, down 0.31% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels near key support at $89. Revenue growth remains strong, reaching $376.57M in 2025, though the company continues to report net losses. Recent news highlights AI-driven drug discovery collaborations and insider selling activity, while analyst consensus leans bullish with a $91.63 price target.
The stock offers growth exposure to synthetic biology and AI-enabled therapeutics, but carries significant risk due to persistent negative cash flow and profitability challenges. Investor sentiment is cautiously optimistic, balancing innovation potential against financial sustainability concerns in a competitive biotech landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
